TLSI Q3 2024 Earnings — TriSalus Life Sciences, Inc. Revenue & Financial Results | Market Cap Arena

TLSITriSalus Life Sciences, Inc.

$175M

Q3 2024 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$7M+41.5% YoY

Gross Profit

$6M86.3% margin

Operating Income

-$9M-118.9% margin

Net Income

-$2M-32.6% margin

EPS (Diluted)

$-0.12

QoQ Revenue Growth

-0.2%

Cash Flow

Operating Cash Flow

-$11M

Free Cash Flow

-$11M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$27M

Total Liabilities

$48M

Stockholders' Equity

-$20M

Cash & Equivalents

$11M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$7M	$5M	+41.5%
Gross Profit	$6M	$5M	+37.8%
Operating Income	-$9M	-$19M	+53.1%
Net Income	-$2M	-$1M	-68.4%